Fig. 5From: The efficacy of tixagevimab/cilgavimab (Evusheld) in prophylaxis and treatment of COVID-19 in immunocompromised patients: a systematic review and meta-analysisThe forest plot demonstrates the association between Evusheld administration as prophylaxis and the rate of COVID-19 infections in the single-armBack to article page